To include your compound in the COVID-19 Resource Center, submit it here.

AMAG, Allos to merge

Hematology company AMAG Therapeutics Inc. (NASDAQ:AMAG) and cancer company Allos Therapeutics Inc. (NASDAQ:ALTH) will merge in a stock deal that values Allos at about

Read the full 248 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE